MediVet Biologics Launches Innovative Immunotherapy Trial for Canine CancerBenzingaK9ACV is a service provided by MediVet Biologics which allows for an affordable personalized immunotherapy vaccine for canine cancer. The immunotherapy cancer vaccine wa… Continue reading
FierceBiotech |
Neon partners up with CRISPR Therapeutics for IO work
FierceBiotech It’s been a good week for Neon: After posting positive cancer vaccine data a few days ago, the Fierce 15 winner has signed a new R&D pact with gene-editing biotech CRISPR Therapeutics. In a brief update, the pair said that the “research collaboration … |
pharmaphorum |
First gene therapy — ‘a true living drug’ — on the cusp of FDA approval
Washington Post The CAR T-cell treatment, manufactured by the drug company Novartis, initially would be available only for the small number of children and young adults whose leukemia doesn’t respond to standard care. Those patients typically have a grim prognosis … Novartis CAR–T safety in FDA spotlightpharmaphorum |
|
BioMarin’s Investigational Gene Therapy for Hemophilia A at 6e13 vg/kg Dose Maintains Average Factor VIII Levels …
Stockhouse BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today an update to its previously reported interim results of an open-label Phase 1/2 study of BMN 270, an investigational gene therapy treatment for severe hemophilia A. The updated results will be … |
|
BioMarin’s Investigational Gene Therapy for Hemophilia A at 6e13 vg/kg Dose Maintains Average Factor VIII Levels …
PR Newswire (press release) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today an update to its previously reported interim results of an open-label Phase 1/2 study of BMN 270, an investigational gene therapy treatment for severe hemophilia A. The updated results will … |
|
Regenerating the Body With Stem Cells – Hype or Hope?
Labiotech.eu (blog) When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state to yield induced pluripotent stem cells (iPSCs), this was supposed to herald a revolution in regenerative medicine. But 10 years after their … Stem Cell Banking Market To Grow at a CAGR of +18% by 2021 According to new researchMedgadget (blog) |